-
Authum Invest
2,250.00 985.45(%) -
Indian Energy Ex
149.45 244.35(%) -
Vimta Labs
598.90 598.90(%) -
Bharti Airtel
1,952.40 2,045.50(%) -
Force Motors
16,488.00 6,128.55(%) -
Bajaj Finance
897.65 642.61(%) -
Anant Raj
606.00 947.25(%) -
Jayaswal Neco
40.05 26.06(%) -
Sharda Cropchem
1,090.25 1,090.25(%) -
Infosys
1,511.35 1,307.10(%) -
Olectra Greentec
1,460.00 973.65(%) -
Tata Motors
685.00 542.55(%) -
Eternal Ltd
306.25 189.60(%) -
Trent
5,033.80 4,491.75(%) -
Reliance Industr
1,384.50 1,115.55(%) -
Waaree Energies
3,171.00 1,808.65(%) -
Phoenix Mills
1,545.00 1,965.00(%) -
Kajaria Ceramics
1,151.00 745.00(%) -
Adani Green
972.75 758.00(%) -
Cipla
1,553.00 1,702.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Torrent Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations
- Torrent
- BSE Code : 3616.0
- ISIN : INE685A01028
-
Today’s Low
3,509.80 -
Today’s High
3,613.90

-
Open
3,523.40 -
Perv Close
3,519.90 -
52W Low
2,886.45 -
52W High
3,613.90
Key Indicators
-
P/E(TTM)
64.43
-
Mar.Cap (₹Cr.)
121,963.49
-
Div & Yield %
0.17
-
Book Value(₹)
224.34
-
Debt-Equity Ratio
2.38
-
AGM Date
25-Jul-2025
-
EPS
55.91
-
P/E Ratio
64.43
Financials Ratios
-
Debt-Equity Ratio
0.72
-
Mar.Cap (₹Cr.)
121,963.49
-
RONW (%)
25.38
-
ROCE (%)
23.21
Score Board
-
Equity (₹ in Cr.)
169.22
-
BV (₹)
224.30
-
Sales( ₹ in Cr.)
9,682.44
-
NP (in Cr.)
1,892.26
-
NP Var(%)
41.0
-
Div%
120.0
-
CPS (₹)
78.40
-
EPS (₹)
55.90
-
Traded Value (₹ in Lakhs)
121,919.49
-
52 Week High
3,613.90
-
52 Week Low
2,886.45
-
Price BSE
3603.0
-
Price NSE
3,604.00
-
Market Capital( in Cr.)
121,919.49
-
P/C Ratio
46.00
-
P/E Ratio
64.40
-
Price Vs.BV
55.90
-
22-Jul-2025( 10:21)
Corporate News - Torre... - Torrent Pharmaceuticals will h...
-
18-Jul-2025( 01:00)
Hot Pursuit - Torre... - <p>Torrent Pharmaceuticals Ltd...
-
05-Jul-2025( 05:16)
Corporate News - Torre... - Torrent Pharmaceuticals announ...
-
30-Jun-2025( 04:02)
Hot Pursuit - Torre... - Shares of JB Chemicals & Pharm...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 9,682.44 | 8,532.90 | 7,695.20 | 6,742.32 | 6,450.57 | 6,168.44 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 9,682.44 | 8,532.90 | 7,695.20 | 6,742.32 | 6,450.57 | 6,168.44 |
Other Income | 31.50 | 91.36 | 81.88 | 204.17 | 118.34 | 236.93 |
Stock Adjustments | 9.04 | 68.61 | -128.44 | 18.34 | 150.14 | 56.83 |
Total Income | 9,722.98 | 8,692.87 | 7,648.64 | 6,964.83 | 6,719.05 | 6,462.20 |
EXPENDITURE : | ||||||
Raw Materials | 2,249.84 | 2,200.39 | 2,010.98 | 1,925.84 | 1,819.81 | 1,694.28 |
Power and Fuel Cost | 134.25 | 143.43 | 153.21 | 140.00 | 122.04 | 126.70 |
Employee Cost | 1,636.45 | 1,450.67 | 1,251.22 | 1,097.93 | 1,097.12 | 1,061.76 |
Other Manufacturing Expenses | 189.02 | 173.82 | 143.39 | 141.56 | 136.19 | 130.43 |
Selling and Administration Expenses | 1,396.83 | 1,254.38 | 1,138.57 | 954.66 | 851.08 | 918.63 |
Miscellaneous Expenses | 533.53 | 489.52 | 404.23 | 399.91 | 382.74 | 376.48 |
Employee Benefit Expenses | 1,636.45 | 1,450.67 | 1,251.22 | 1,097.93 | 1,097.12 | 1,061.76 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 6,139.92 | 5,712.21 | 5,101.60 | 4,659.90 | 4,408.98 | 4,308.28 |
Operating Profit | 3,583.06 | 2,980.66 | 2,547.04 | 2,304.93 | 2,310.07 | 2,153.92 |
Interest | 213.40 | 303.04 | 297.68 | 236.29 | 334.12 | 430.49 |
Gross Profit | 3,369.66 | 2,677.62 | 2,249.36 | 2,068.64 | 1,975.95 | 1,723.43 |
Depreciation | 759.48 | 761.05 | 672.34 | 602.43 | 609.84 | 606.66 |
Profit Before Tax | 2,610.18 | 1,916.57 | 1,577.02 | 1,466.21 | 1,366.11 | 1,116.77 |
Current Tax | 540.56 | 321.67 | 274.20 | 253.27 | 247.77 | 192.13 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 181.56 | 237.82 | 251.43 | 221.49 | -19.51 | -13.87 |
Reported Net Profit | 1,888.06 | 1,357.08 | 1,051.39 | 991.45 | 1,137.85 | 938.51 |
Extraordinary Items | -4.20 | 14.88 | 27.97 | 6.86 | 12.75 | 24.18 |
Adjusted Net Profit | 1,892.26 | 1,342.20 | 1,023.42 | 984.59 | 1,125.10 | 914.33 |
Adjustment below Net Profit | -27.14 | 0.44 | -7.07 | -1.55 | 7.21 | -120.06 |
P & L Balance brought forward | 3,736.39 | 3,394.21 | 3,212.92 | 2,899.91 | 2,093.30 | 1,884.05 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 1,082.98 | 1,015.34 | 863.03 | 676.89 | 338.45 | 609.20 |
P & L Balance carried down | 4,514.33 | 3,736.39 | 3,394.21 | 3,212.92 | 2,899.91 | 2,093.30 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 120.00 | 560.00 | 440.00 | 960.00 | 700.00 | 640.00 |
Dividend Per Share(Rs) | 6.00 | 28.00 | 22.00 | 48.00 | 35.00 | 32.00 |
Earnings Per Share-Unit Curr | 55.78 | 40.10 | 31.06 | 58.58 | 67.23 | 55.45 |
Earnings Per Share(Adj)-Unit Curr | 55.78 | 40.10 | 31.06 | 29.29 | 33.62 | 27.73 |
Book Value | 224.32 | 201.76 | 190.75 | 374.94 | 356.30 | 302.59 |
Book Value(Adj)-Unit Curr | 224.32 | 201.76 | 190.75 | 187.47 | 178.15 | 151.30 |